Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection
ANZ Journal of Surgery · 2024-10 · 94 (10) · 1693-1701
DOI: 10.1111/ans.19183 ↗Kurz gefasst
Metaanalyse in der Zeitschrift ANZ Journal of Surgery, online erschienen am 05.08.2024. Verfasst von Amanda Koh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery, Nottingham Digestive Diseases Centre and National Institute for Health Research Nottingham Biomedical Research Centre, Nott…. Hauptthemen laut MEDLINE: Acetylcysteine, Hepatectomy, Postoperative Complications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background
N‐Acetylcysteine (NAC) is a recognized antioxidative agent that facilitates the conjugation of toxic metabolites. In recent years, NAC has been routinely used to limit ischaemia‐reperfusion injury in liver transplantation. There remains, however, contradictory evidence on its effectiveness in liver resection. This meta‐analysis examines the effectiveness of NAC in improving outcomes following hepatectomy.
Methods
A comprehensive search of the MEDLINE, EMBASE, and Cochrane databases was performed to identify relevant randomized controlled trials (RCTs) published since database inception until November 2023. The outcomes of Day 1 biochemical markers (lactate, ALT, bilirubin, and INR), length of stay, transfusion rates, and morbidity were extracted. Quantitative pooling of data was based on a random‐effects model. The study protocol was registered on PROSPERO (Registration no: CRD42023442429).
Results
Five RCTs reporting on 388 patients undergoing hepatectomy were included in the analysis. There were no significant differences in patient demographics between groups. Post‐operative lactate was lower in patients receiving NAC (WMD −0.61, 95% CI −1.19 to −0.04, I 2 = 67%). There were, however, no differences in the post‐operative INR (WMD −0.04, 95% CI −0.19 to 0.12, I 2 = 96%) and ALT (WMD ‐94.94, 95% CI −228.46 to 40.38; I 2 = 67%). More importantly, there were no statistically significant differences in length of stay, transfusion rates, and morbidity between the two groups.
Conclusion
The administration of NAC in liver resection did not alter important biochemical parameters suggesting any real effectiveness in reducing hepatic dysfunction. There were no improvements in the clinical outcomes of length of stay, transfusion rates, and overall morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Surgery, Nottingham Digestive Diseases Centre and National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Qu…
ORCID-Profile: Amanda Koh, Alfred Adiamah, Sudip Sanyal
Zitieren
APA
Koh, A., Wong, T., Adiamah, A., & Sanyal, S. (2024). Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection. ANZ Journal of Surgery, 94(10), 1693-1701. https://doi.org/10.1111/ans.19183
Vancouver
Koh A, Wong T, Adiamah A, Sanyal S. Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection. ANZ Journal of Surgery. 2024;94(10):1693-1701. doi:10.1111/ans.19183
BibTeX
@article{Koh2024,
author = {Koh, Amanda and Wong, Tiffany and Adiamah, Alfred and Sanyal, Sudip},
title = {Systematic review and meta‐analysis of the effect of N‐acetylcysteine on outcomes after liver resection},
journal = {ANZ Journal of Surgery},
year = {2024},
volume = {94},
number = {10},
pages = {1693--1701},
doi = {10.1111/ans.19183}
}
EUVIMED